HRSA - HHS - RYAN WHITE PART A PARTIAL NOA - 5 H89HA11478-18-00 NOA 2026.PDF

Department of Health and Human Services 
Health Resources and Services Administration
Notice of Award 
FAIN#  H8911478 
Federal Award Date:  01/30/2026
Recipient Information
1. Recipient Name
Maricopa County
301 W Jefferson St
Phoenix, AZ 85003‐2143
2. Congressional District of Recipient
03
3. Payment System Identifier (ID)
1866000472A8
4. Employer Identification Number (EIN)
866000472
5. Data Universal Numbering System (DUNS)
602062515
6. Recipient's Unique Entity Identifier
LM85MG1513K5
7. Project Director or Principal Investigator
Jeremy Hyvarinen
Ryan White Subdivision Manager
jeremy.hyvarinen@maricopa.gov
(602)647‐2996
8. Authorized Official
Arthur Orville
arthur.orville@maricopa.gov
(602)509‐1523
Federal Agency Information
9. Awarding Agency Contact Information
Olusola Dada
Grants Management Specialist
Office of Federal Assistance Management (OFAM)
Division of Grants Management Office (DGMO)
ODada@hrsa.gov
(301) 443‐0195
10. Program Official Contact Information
Krystal Hilton
HIV/AIDS Bureau (HAB)
khilton@hrsa.gov
(301) 945‐5220
Federal Award Information
11. Award Number
5 H89HA11478‐18‐00
12. Unique Federal Award Identification Number (FAIN)
H8911478
13. Statutory Authority
42 U.S.C. § 300ff‐11‐20 and § 300ff‐121
14. Federal Award Project Title
Ryan White Part A HIV Emergency Relief Grant Program
15. Assistance Listing Number
93.914
16. Assistance Listing Program Title
HIV Emergency Relief Project Grants
17. Award Action Type
Noncompeting Continuation
18. Is the Award R&D?
No
Summary Federal Award Financial Information   
19. Budget Period Start Date 03/01/2026 ‐ End Date 02/28/2027   
20. Total Amount of Federal Funds Obligated by this Action
$3,270,266.00
     20a. Direct Cost Amount
     20b. Indirect Cost Amount
$0.00
21. Authorized Carryover
$0.00
22. Offset
$0.00
23. Total Amount of Federal Funds Obligated this budget period
$3,270,266.00
24. Total Approved Cost Sharing or Matching, where applicable
$0.00
25. Total Federal and Non‐Federal Approved this Budget Period
$3,270,266.00
26. Project Period Start Date 03/01/2025 ‐ End Date 02/29/2028   
27. Total Amount of the Federal Award including Approved
Cost Sharing or Matching this Project Period
$14,697,424.00
28. Authorized Treatment of Program Income
Addition   
29. Grants Management Officer – Signature
Sarah Hammond on 01/30/2026
30. Remarks
This award consists of the following amounts:
FY26 Formula: $3,069,007
FY26 MAI: $201,259
Total Award: $3,270,266
Page 1
A printer version document only. The document may contain some accessibility challenges for the screen reader users. To access same information, a fully 508 compliant accessible HTML version is available on the HRSA Electronic Handbooks. If you need more
information, please contact HRSA contact center at 877-464-4772, 8 am to 8 pm ET, weekdays.

HIV/AIDS Bureau (HAB)
Notice of Award
Award Number: 5 H89HA11478‐18‐00 
Federal Award Date:  01/30/2026
31. APPROVED BUDGET: (Excludes Direct Assistance)
 [X] Grant Funds Only
 [  ]
Total project costs including grant funds and all other financial participation
a.
Salaries and Wages:
$0.00
b.
Fringe Benefits:
$0.00
c.
Total Personnel Costs:
$0.00
d.
Consultant Costs:
$0.00
e.
Equipment:
$0.00
f.
Supplies:
$0.00
g.
Travel:
$0.00
h.
Construction/Alteration and Renovation:
$0.00
i.
Other:
$0.00
j.
Consortium/Contractual Costs:
$0.00
k.
Trainee Related Expenses:
$0.00
l.
Trainee Stipends:
$0.00
m. Trainee Tuition and Fees:
$0.00
n.
Trainee Travel:
$0.00
o.
TOTAL DIRECT COSTS:
$3,270,266.00
p.
INDIRECT COSTS (Rate: % of S&W/TADC):
$0.00
 
    i. Indirect Cost Federal Share:
$0.00
 
   ii. Indirect Cost Non-Federal Share:
$0.00
q.
TOTAL APPROVED BUDGET:
$3,270,266.00
 
    i. Less Non‐Federal Share:
$0.00
 
 
   ii. Federal Share:
$3,270,266.00
 
32. AWARD COMPUTATION FOR FINANCIAL ASSISTANCE:
a. Authorized Financial Assistance This Period
$3,270,266.00
 
b. Less Unobligated Balance from Prior Budget Periods
 
     i. Additional Authority
$0.00
 
    ii. Offset
$0.00
 
c. Unawarded Balance of Current Year's Funds
$0.00
 
d. Less Cumulative Prior Award(s) This Budget Period
$0.00
 
e. AMOUNT OF FINANCIAL ASSISTANCE THIS ACTION
 $3,270,266.00
 
33. RECOMMENDED FUTURE SUPPORT: 
(Subject to the availability of funds and satisfactory progress of project) 
YEAR
TOTAL COSTS
19
$3,270,266.00
34. APPROVED DIRECT ASSISTANCE BUDGET: (In lieu of cash)
a. Amount of Direct Assistance
$0.00
b. Less Unawarded Balance of Current Year's Funds
$0.00
c. Less Cumulative Prior Award(s) This Budget Period
$0.00
d. AMOUNT OF DIRECT ASSISTANCE THIS ACTION
$0.00
35. FORMER GRANT NUMBER
6 H89HA00031‐15‐02
36. OBJECT CLASS
41.15
37. BHCMIS#
38. THIS AWARD IS BASED ON THE APPLICATION APPROVED BY HRSA FOR THE PROJECT NAMED IN ITEM 14. FEDERAL AWARD PROJECT TITLE AND IS SUBJECT TO THE
TERMS AND CONDITIONS INCORPORATED EITHER DIRECTLY OR BY REFERENCE AS: 
a. The program authorizing statue and program regulation cited in this Notice of Award; b. Conditions on activities and expenditures of funds in certain other applicable
statutory requirements, such as those included in appropriations restrictions applicable to HRSA funds; c. 45 CFR Part 75; d. National Policy Requirements and all other
requirements described in the HHS Grants Policy Statement; e. Federal Award Performance Goals; and f. The Terms and Conditions cited in this Notice of Award. In the event
there are conflicting or otherwise inconsistent policies applicable to the award, the above order of precedence shall prevail. Recipients indicate acceptance of the award, and
terms and conditions by obtaining funds from the payment system.
39. ACCOUNTING CLASSIFICATION CODES
FY‐CAN
CFDA
DOCUMENT
NUMBER
AMT. FIN. ASST.
AMT. DIR. ASST.
SUB PROGRAM CODE
SUB ACCOUNT CODE
26 - 377RA34
93.914
26H89HA11478
$3,069,007.00
$0.00
FRML
26H89HA11478
26 - 377RA33
93.914
26H89HA11478
$201,259.00
$0.00
MAI
26H89HA11478
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/30/2026 1:26:21 PM
Award Number: 5 H89HA11478-18-00
Page 2

HRSA Electronic Handbooks (EHBs) Registration Requirements
The Project Director of the grant (listed on this NoA) and the Authorizing Official of the grantee organization are required to register (if not already
registered) within HRSA's Electronic Handbooks (EHBs). Registration within HRSA EHBs is required only once for each user for each
organization they represent. To complete the registration quickly and efficiently we recommend that you note the 10-digit grant number from box
4b of this NoA. After you have completed the initial registration steps (i.e.,created an individual account and associated it with the correct grantee
organization record), be sure to add this grant to your portfolio. This registration in HRSA EHBs is required for submission of noncompeting
continuation applications. In addition, you can also use HRSA EHBs to perform other activities such as updating addresses, updating email
addresses and submitting certain deliverables electronically. Visit
https://grants3.hrsa.gov/2010/WebEPSExternal/Interface/common/accesscontrol/login.aspx to use the system. Additional help is available online
and/or from the HRSA Call Center at 877-Go4-HRSA/877-464-4772.
Terms and Conditions
Failure to comply with the remarks, terms, conditions, or reporting requirements may result in a draw down restriction being placed
on your Payment Management System account or denial of future funding.
Grant Specific Term(s)
1.
 
By applying for or accepting federal funds from HHS, recipients certify compliance with all federal antidiscrimination laws and these
requirements and that complying with those laws is a material condition of receiving federal funding streams. Recipients are responsible for
ensuring subrecipients, contractors, and partners also comply.
2.
 
Applicable Regulations – Prior to October 1, 2025, this award is subject to 45 CFR 75 except for eight flexibilities from 2 CFR 200 adopted
by HHS on October 1, 2024, in Federal Register Notice 89 FR 80055. After October 1, 2025, this award will be subject to any applicable
provisions of 2 CFR 200 and 2 CFR 300.
3.
 
The Recipient hereby agrees that it will comply with Title VI of the Civil Rights Act of 1964, as amended (codified at 42 U.S.C. 2000d et
seq.), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 C.F.R. Part 80);
Section 504 of the Rehabilitation Act of 1973, as amended (codified at 29 U.S.C. 794), and all requirements imposed by or pursuant to the
Regulation of the Department of Health and Human Services (45 C.F.R. Part 84); Title IX of the Education Amendments of 1972, as
amended (codified at 20 U.S.C. § 1681 et seq.), and all requirements imposed by or pursuant to the Regulation of the Department of Health
and Human Services (45 C.F.R. Part 86); The Age Discrimination Act of 1975, as amended (codified at 42 U.S.C. § 6101 et seq.), and all
requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 C.F.R. Part 91); and Section
1557 of the Patient Protection and Affordable Care Act, as amended (codified at 42 U.S.C. § 18116), and all requirements imposed by or
pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 92).
4.
 
Any term or condition in this NOA, including those incorporated by reference, that HHS is enjoined by court order from imposing or enforcing
shall not apply or be enforced as to any recipient or subrecipient to which that court order applies and while that court order is in effect.
5.
 
Funding beyond this budget period is contingent upon the availability of appropriated funds for this program, recipient satisfactory
performance, program authority, compliance with the Terms and Conditions of the award, and a decision that continued funding is in the best
interest of the Federal government.
This award action is based on HRSA’s approval of the recipient’s application and any modifications at the time of this award. Continued
support for this award may be subject to other programmatic considerations to the extent permitted by law, including, but not limited to,
Administration priorities and court orders.
Should additional federal funds not be available and/or shifting priorities affect the programmatic objectives of this award, the recipient will
work with HRSA to revise any workplan tasks and budget in accordance with 45 CFR 75.308 (Revision of budget and program plans).
6.
 
This Notice of Award is issued based on HRSA’s approval of the Non-Competing Continuation (NCC) Progress Report. All post-award
requests, such as significant budget revisions or a change in scope, must be submitted as a Prior Approval action via the Electronic
Handbooks (EHBs) and approved by HRSA prior to implementation. Grantees under “Expanded Authority,” as noted in the Remarks section
of the Notice of Award, have different prior approval requirements. See “Prior-Approval Requirements” in the DHHS Grants Policy
Statement: https://www.hhs.gov/sites/default/files/hhs-grants-policy-statement-october-2024.pdf
.
7.
 
Prior to October 1, 2025, this award is subject to the termination provisions at 45 CFR 75.372. Starting on October 1, 2025, this award is
subject to the termination provisions at 2 CFR 200.340. Pursuant to 2 CFR 200.340, the recipient agrees by accepting this award that
continued funding for the award is contingent upon the availability of appropriated funds, recipient satisfactory performance, compliance with
the Terms and Conditions of the award, and to the extent authorized by law, a decision by the agency that the award continues to effectuate
program goals or agency priorities.
8.
 
By accepting this award, including the obligation, expenditure, or drawdown of award funds, recipients, whose programs are covered by Title
IX, certify as follows:
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/30/2026 1:26:21 PM
Award Number: 5 H89HA11478-18-00
Page 3

• Recipient is compliant with Title IX of the Education Amendments of 1972, as amended, 20 U.S.C. §§ 1681 et seq., including the
requirements set forth in Presidential Executive Order 14168 titled Defending Women From Gender Ideology Extremism and Restoring
Biological Truth to the Federal Government, and Title VI of the Civil Rights Act of 1964, 42 U.S.C. §§ 2000d et seq., and Recipient will
remain compliant for the duration of the Agreement.
• The above requirements are conditions of payment that go the essence of the Agreement and are therefore material terms of the
Agreement.
• Payments under the Agreement are predicated on compliance with the above requirements, and therefore Recipient is not eligible for
funding under the Agreement or to retain any funding under the Agreement absent compliance with the above requirements.
• Recipient acknowledges that this certification reflects a change in the government’s position regarding the materiality of the foregoing
requirements and therefore any prior payment of similar claims does not reflect the materiality of the foregoing requirements to this
Agreement.
• Recipient acknowledges that a knowing false statement relating to Recipient’s compliance with the above requirements and/or eligibility for
the Agreement may subject Recipient to liability under the False Claims Act, 31 U.S.C. § 3729, and/or criminal liability, including under 18
U.S.C. §§ 287 and 1001.
9.  This award is subject to 2 CFR 200--Uniform Administrative Requirements, Cost Principles, and Audit Requirement for HHS Awards.
10.
 
During each budget period, recipients must include in their program budget travel support for recipient staff members to attend
meetings/conferences identified by HRSA HAB as essential to RWHAP administration and implementation. HRSA HAB meetings may
include, but are not limited to, the biennial National Ryan White Conference on HIV Care and Treatment, grant-specific Administrative
Reverse Site Visits (ARSV), or targeted technical assistance events. Meetings are generally held in the Washington, D.C. metropolitan
area. If no essential meetings are held during the budget period, recipients can reallocate funds for other allowable grant expenses.
Recipients must comply with 2 CFR 200.475 and all other applicable HHS and Federal policies governing travel supported under Federal
assistance awards.
11.
 
This Notice of Award is issued to approve the Core Medical Services Waiver Request for budget period FY 2026, which waives the
statutory requirement that not less than 75 percent of grant funds be used for provision of core medical services. Subsequent budget
periods will require a new waiver request. All previously conveyed terms and conditions remain in effect unless specifically removed.
Program Specific Term(s)
1.
 
RWHAP Part A recipients are required to use a minimum amount/percentage of this award to provide services to women, infants, children
and youth (WICY) living with HIV/AIDS. The minimum set-aside amounts/percentages for each eligible metropolitan area/transitional grant
area (EMA/TGA) must be determined separately for each priority population, and may not be less than the percentage of each population to
the total number of persons estimated to be living with HIV/AIDS within the EMA/TGA.
Waiver: If the recipient can document that one or more WICY priority populations are receiving HIV-related services through the state
Medicaid program under Title XIX of the Social Security Act, the Children’s Health Program (CHIP) under Title XXI of the same Act, or other
qualified federal or state programs in accordance with HRSA guidelines, then the recipient may request a waiver of the minimum WICY
expenditure requirement from HRSA. Recipients requesting a waiver may utilize the WICY Expenditure Report to document that all priority
populations are receiving HIV/AIDS health services through other funding sources
2.
 
The recipient is required to notify the Project Officer, within 30 days, of any changes to Planning Council (PC) composition that impact
legislative compliance with "reflectiveness", the mandated membership categories, and/or the composition requirement that 33% of the PC
membership should be comprised of persons receiving Part A HIV-related services who are non-conflicted and accurately reflect he
demographics of the epidemic in the EMA/TGA. 
You must notify your Project Officer to initiate a Request for Information via EHB to submit this requirement. The notification and letter must
be accompanied by revised PC roster and reflectiveness tables or a narrative describing compliance with PC composition and
Reflectiveness. 
Reflectiveness must be based on the prevalence of HIV Disease (AIDS Prevalence plus HIV Prevalence, real or estimated) in the EMA/TGA
as reported in the current fiscal year application. 
3.
 
Consistent with Departmental guidance, HRSA recipients that purchase, are reimbursed or provide reimbursement to other entities for
outpatient prescription drugs are expected to secure the best prices available for such products and to maximize results for the recipient
organization and its patients. Eligible health care organizations/covered entities that enroll in the 340B Program must comply with all 340B
Program requirements and will be subject to audit regarding 340B Program compliance. 340B Program requirements, including eligibility,
can be found at www.hrsa.gov/opa.
4.
 
The recipient shall make all files, including captioning, audio descriptions, videos, tables, graphics/pictures, registration forms, presentations
(both audio and video) or other types of proprietary format files – e.g., Adobe Portable Document Format (.pdf), Microsoft Office PowerPoint
(.ppt) and Microsoft Excel (.xls), fully accessible to members of the public with disabilities. Technical and functional standards for accessibility
are codified at 36 CFR Part 1194 and may be accessed through the Access Board’s Web site at http://www.access-board.gov
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/30/2026 1:26:21 PM
Award Number: 5 H89HA11478-18-00
Page 4

5.
 
Every two (2) years to the lead State agency for the Ryan White HIV/AIDS Program (RWHAP) Part B, the recipient must submit audits
consistent with 2 CFR 200 Subpart F regarding funds expended in accordance with Title XXVI of the Public Health Service Act. Include
necessary client level data to complete unmet need calculations and the Statewide Coordinated Statements of Need process.
6.
 
Jurisdictions that 1) are legislatively mandated to establish planning councils or 2) have elected to establish a planning council, must adhere
to the requirement that the chief elected official (CEO) retains sole responsibility for appointment and removal of planning council members,
as recommended by Planning Council leadership.
7.
 
In accordance with the RWHAP guidance on determining client eligibility and complying with the payor of last resort requirement, while
minimizing administrative burden and enhancing continuity of care and treatment services (HRSA HAB PCN 21-02: Determining Client
Eligibility & Payor of Last Resort in the Ryan White HIV/AIDS Program), HRSA HAB expects all RWHAP recipients and subrecipients to
establish, implement, and monitor policies and procedures to determine client eligibility based on each of the three factors outlined in PCN
21-02, including documentation requirements. See https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/pcn-21-02-determining-
eligibility-polr.pdf
8.
 
The recipient is required to establish and maintain a process for protecting client confidentiality throughout the project period. Client
confidentiality requirements apply to all phases of the project.
9.
 
HRSA is operating under a Continuing Resolution; therefore, this award provides partial funding based on the continuation of FY 2025
program requirements, funding levels, and specialized reporting requirements. Additions and revisions to these Terms and Conditions may
be necessary once HRSA receives a final FY 2026 appropriations. A revised NoA will be issued to reflect any changes to funding amounts,
Terms and Conditions, and/or reporting requirements.
10.
 
All Ryan White HIV/AIDS Program Part A, B, C, and D recipients must adhere to the legislative requirement to establish a clinical quality
management program. HRSA HIV/AIDS Bureau expectations for clinical quality management are outlined in Policy Clarification Notice 15-
02 (https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/pcn-15-02-cqm.pdf).
11.
 
The Ryan White HIV/AIDS Program legislation specifies criteria for the expenditure of Part A funds as follows:
The recipient may not use more than ten percent (10%) of total grant funds for direct and indirect costs associated with administering the
award (including Planning Council or planning body expenses), and in accordance with the legislative definition of administrative activities
and the allocation of funds to subrecipients, will not exceed an aggregate amount of 10 percent of such funds for administrative purposes.
See Policy 15-01 for additional information on the 10% administrative cap. 
The recipient shall not exceed the lesser of 5 percent of the total grant funds or $3 million for the required clinical quality management
(CQM) program. 
The recipient must expend not less than 75% of total grant funds, exclusive of administration and CQM expenses, for core medical
services, unless waived by the Secretary. Also see PCN 16-02 Ryan White HIV/AIDS Program Services: Eligible Individuals & Allowable
Uses of Funds.
12.
 
Unless otherwise specified, all Conditions and Reporting Requirements must be electronically submitted through the HRSA Electronic
Handbooks (EHBs).
13.
 
Funds awarded for pharmaceuticals must only be spent to assist clients who have been determined not eligible for other pharmaceutical
programs, especially the AIDS Drug Assistance Program and/or for drugs that are not on the State ADAP or Medicaid formulary.
14.
 
These funds may not be used for the following: purchasing or construction of real property, international travel, payments for any item or
service to the extent that payment has been made, or reasonably can be expected to be made, with respect to that item or service under
any State compensation program, insurance policy, Federal or State health benefits program or by an entity that provides health services
on a prepaid basis (except for a program administered by or providing the services of the Indian Health Services or the U.S. Department of
Veterans Affairs; see HAB PCN 16-01 available online at https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/clarification-
services-veterans.pdf for additional information regarding services provided to veterans).
15.
 
RWHAP funds may not be used to make cash payments to intended clients of core medical or support services. This prohibition includes
cash incentives and cash intended as payment for RWHAP services. Where direct provision of the service is not possible or effective,
store gift cards, vouchers, coupons, or tickets that can be exchanged for a specific service or commodity (e.g., food or transportation) must
be used. Store gift cards that can be redeemed at one merchant or an affiliated group of merchants for specific goods or services that
further the goals and objectives of the RWHAP are also allowable as incentives for eligible program participants. Recipients are advised to
administer voucher and store gift card programs in a manner which assures that vouchers and gift cards cannot be exchanged for cash or
used for anything other than allowable goods or services, and that systems are in place to account for disbursed vouchers and store gift
cards. Note: General-use prepaid cards are considered “cash equivalent” and are therefore unallowable. Such cards generally bear the
logo of a payment network, such as Visa, MasterCard, or American Express, and are accepted by any merchant that accepts those credit
or debit cards as payment. Gift cards that are cobranded with the logo of a payment network and the logo of a merchant or affiliated group
of merchants are general-use prepaid cards, not store gift cards, and therefore are also unallowable.
16. The Ryan White HIV/AIDS Program (RWHAP) legislation requires, to the maximum extent practicable, that core medical and support
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/30/2026 1:26:21 PM
Award Number: 5 H89HA11478-18-00
Page 5

services will be provided without regard to an individual’s ability to pay, or to the current or past health condition of the individual to be
served. Consequently, HRSA expects that RWHAP recipients and subrecipients utilize a grievance process, articulated in writing, to
investigate complaints for denial of services. 
17.
 
Recipients must follow the guidance in all applicable HIV/AIDS Bureau Policy Notices and Program Letters to ensure compliance with
programmatic requirements. See https://ryanwhite.hrsa.gov/grants/policy-notices and https://ryanwhite.hrsa.gov/grants/program-letters.
18.
 
In accordance with Policy Clarification Notice 16-02, grant funds may not be used for outreach programs which have HIV prevention
education as their exclusive purpose. See https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/service-category-pcn-16-02-
final.pdf.
19.
 
RWHAP Part A recipients are required to participate in the development of the Integrated HIV Prevention and Care Plan, including the
Statewide Coordinated Statement of Need (SCSN), CY 2027-2031 (see
https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/integrated-hiv-prevention-care-plan-guidance-2027-2031.pdf). The SCSN is a
component of the Integrated HIV Prevention and Care Plan.
Recipients are required to report progress on the implementation of Integrated HIV Prevention and Care Plans in the FY 2026 RWHAP
Part A Annual Progress Report.
20.
 
The recipient must maintain EMA/TGA political subdivision expenditures for HIV-related activities at a level which is not less than the level
of expenditures for such activities during the one-year period preceding the fiscal year for which the applicant is applying to receive the
grant (see Section 2605(a)(1)(B) of the PHS Act).
21.
 
All providers of services available in the Medicaid State plan must have entered into a participation agreement under the State plan and be
qualified to receive payments under such plan, or receive a waiver from this requirement.
22.
 
Minority AIDS Initiative (MAI) funds available under Section 2693 of the Public Health Service Act are disbursed on a formula basis
together with the RWHAP Part A formula grant funds as required by legislation. Funds must be used to improve HIV-related health
outcomes to reduce existing racial and ethnic disparities. MAI funds must be tracked and reported separately.
23.
 
RWHAP Part A recipients are required to meet specific legislative, programmatic, and grant regulations requirements regarding the
monitoring of both their grant and their subrecipients. Guidance for compliance is detailed in the National Monitoring Standards for
RWHAP recipients. (https://ryanwhite.hrsa.gov/grants/manage/recipient-resources)
24.
 
Recipients must submit an annual Non-Competing Continuation (NCC) progress report via the HRSA EHBs within 150 days prior to the
budget period end date. Please refer to HRSA EHBs for the specific due date. Submission and HRSA approval of this NCC progress
report triggers the budget period renewal and release of subsequent year funds.
25.
 
Prior approval for rebudgeting is required when for awards that exceed the simplified acquisition threshold (set by 48 CFR 2.101),
specifically cumulative transfers among direct cost budget categories (i.e., Personnel, Fringe, Travel, Equipment, Supplies, Contractual,
etc.) for the current budget period exceed 10% of the total approved budget (which includes direct and indirect costs) for that budget
period; or substantial changes are made to the approved work plan or project scope (e.g., changing the model of care, transferring
substantive work from personnel to contractual); or the recipient wants to purchase a piece of equipment that exceeds $10,000 and was not
included in the approved project budget/application. Any of the aforementioned post-award changes in Part A and/or Minority AIDS
Initiative (MAI) grant allocations must be submitted to the Project Officer via prior approval along with a letter of concurrence from the
Planning Council Chair(s).
26.
 
Due to the provision of partial funding, this award is being made without itemized reporting requirements. Award recipients are reminded of
the continuation of FY2025 specialized reporting requirements and provided reference to previous HRSA guidelines and instructions.
Subsequent FY2026 reporting requirements to include defined due dates will be contained on the final FY2026 NoA. Failure to comply with
reporting requirements will result in deferral or additional restrictions for future funding decisions.
27.
 
This action reflects a new document number. Please refer to this number when contacting the Payment Management System or submitting
drawdown requests. Reporting on the Federal Financial Report (FFR) SF-425 Federal Cash Transaction Report (FCTR) should reflect this
number for all disbursements related to this project period.
28.
 
Ryan White HIV/AIDS Program (RWHAP) funds cannot pay for pre-exposure prophylaxis (PrEP) or non-occupational Post-Exposure
Prophylaxis (nPEP) as the person using PrEP is not an individual living with HIV and the person using nPEP is not diagnosed with HIV prior
to the exposure and therefore are not eligible for RWHAP funded medications or medical services. RWHAP Parts A and B recipients and
subrecipients may provide some limited services under the EIS service category. (See the HIV/AIDS Bureau June 22, 2016 Program Letter
available online at https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/prep-letter-06-22-2016.pdf.)
29.
 
Recipients are required to track and report all sources of service reimbursement as program income on the annual Federal Financial
Report and in annual data reports. All program income earned must be used to further the objectives of the RWHAP program. For
additional information, see PCN #15-03 available online at https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/pcn-15-03-
program-income.pdf 
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/30/2026 1:26:21 PM
Award Number: 5 H89HA11478-18-00
Page 6

30.
 
The funds for this award are sub-accounted in the Payment Management System (PMS) and will be in a P type (sub accounted) account.
This type of account allows recipients to specifically identify the individual grant for which they are drawing funds and will assist HRSA in
monitoring the award. The P sub account number and the sub account code (provided on page 1 of this Notice of Award) are both needed
when requesting grant funds. You may use your existing PMS username and password to check your organizations P account access. If you
do not have access, fill out a New User Access Request form at: 
https://pmsapp.psc.gov/pms/app/userrequest/request/newuser?. If you have any questions about accessing PMS, contact the PMS Liaison
Accountant as identified at: https://pms.psc.gov/find-pms-liaison-accountant.html. 
31.
 
The Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards, 2 CFR 200.332, requires recipients
to monitor the activities of subrecipients to ensure funding is used only for authorized purposes, in compliance with federal statutes,
regulations, and the terms and conditions of the subaward, as well as to ensure that performance goals are achieved. To meet the
monitoring requirements, RWHAP Parts A and B recipients must conduct annual subrecipient site visits. Recipients must ensure that drug
rebates and program income earned as a result of the RWHAP award are used only for allowable activities and only for purposes of the
RWHAP award. See section 2616(g) of the Public Health Service Act and 2 CFR 200.307(b)(2). Therefore, recipients must monitor
awards funded through drug rebates and/or program income.
32.
 
Some aspects of Syringe Services Programs are allowable with HRSA's prior approval and in compliance with HHS and HRSA policy. See
https://www.hiv.gov/federal-response/policies-issues/syringe-services-programs.
33.
 
If applicable, recipients must submit the Tangible Personal Property Report (TPPR) (SF-428) and any related forms. The report must be
submitted within 90 days after the project period ends. Recipients are required to report all equipment with an acquisition cost of $10,000
or more per unit acquired by the recipient with award funds. TPPRs must be submitted electronically through HRSA EHBs.
34.
 
Funds may not be used by recipients for the purchase of vehicles without written prior approval from the Division of Grants Management
Operations (DGMO).
Standard Term(s)
1.
 
Your organization must have policies, procedures, and financial controls to follow all the General Terms and Conditions. HRSA awards are
based on the application submitted and approved by HRSA. All awards are subject to the General Terms and Conditions, in addition to
those included in the Notice of Award or referenced in documents and attachments.
Reporting Requirement(s)
1.
 
Due Date: Annually (Budget Period) Beginning: Budget Start Date Ending: Budget End Date, due 90 days after end of reporting
period.
The recipient must submit, within 90 days after budget period end date, an annual Federal Financial Report (FFR). The report should reflect
cumulative reporting within the project period of the document number. All FFRs must be submitted through the Payment Management
System (PMS). Technical questions regarding the FFR, including system access should be directed to the PMS Help Desk by submitting a
ticket through the self-service web portal (PMS Self-Service Web Portal), or calling 877-614-5533.
2.
 
Due Date: 12/31/2026
The recipient must submit an estimate of their FY 2026 Unobligated Balances (UOB) and an estimated carryover request no later than
December 31, 2026, consistent with reporting guidelines, instructions, and/or reporting templates provided in the HRSA EHBs.
3.
 
Due Date: 05/29/2027
The recipient must submit a Final FY 2026 Part A Annual Progress Report no later than 90 days after the budget period end date, consistent
with reporting guidelines, instructions, and/or reporting templates provided in the HRSA EHBs.
4.
 
Due Date: Within 90 Days of Budget End Date
The recipient must submit the Ryan White HIV/AIDS Program Expenditure Report no later than 90 days after the budget period end date,
consistent with reporting guidelines, instructions, and/or reporting templates provided in the HRSA EHBs.
5.
 
Due Date: 03/29/2027
Submit the Ryan White Services Report (RSR) which consists of recipient, service provider, and patient level reports for the calendar year
via the EHBs by 6:00 PM ET on the last Monday in March. See http://hab.hrsa.gov/manageyourgrant/reportingrequirements.html for
additional information.
6.
 
Due Date: 06/30/2026
The recipient must submit the Integrated HIV Prevention and Care Plan, including the Statewide Coordinated Statement of Need, CY 2027-
2031, consistent with the Centers for Disease Control and Prevention and Health Resources and Services Administration’s Integrated HIV
Prevention and Care Plan Guidance, including the Statement Coordinated Statement of Need, CY 2027-2031. The guidance is available
online: https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/grants/integrated-hiv-prevention-care-plan-guidance-2027-2031.pdf.
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/30/2026 1:26:21 PM
Award Number: 5 H89HA11478-18-00
Page 7

Failure to comply with these reporting requirements will result in deferral or additional restrictions of future funding decisions.
 
Contacts
NoA Email Address(es):  
Name
Role
Email
Alaina Rinne
Business Official
alaina.rinne@maricopa.gov
Arthur Orville
Authorizing Official
arthur.orville@maricopa.gov
Jeremy Hyvarinen
Program Director
jeremy.hyvarinen@maricopa.gov
Note: NoA emailed to these address(es)
 
All submissions in response to conditions and reporting requirements (with the exception of the FFR) must be submitted via EHBs. Submissions
for Federal Financial Reports (FFR) must be completed in the Payment Management System (https://pms.psc.gov/).
                                                                                                        
NOTICE OF AWARD (Continuation Sheet)
Date Issued: 1/30/2026 1:26:21 PM
Award Number: 5 H89HA11478-18-00
Page 8